Report error Found 167 Enz. Inhib. hit(s) with all data for entry = 50023482
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of RET V804L mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of RET V804L mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of RET M918T mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of RET V804L mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of RET V804L mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of RET M918T mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Inhibition of RET M918T mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Inhibition of RET V804L mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 1.20nMAssay Description:Inhibition of RET M918T mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 1.5nMAssay Description:Inhibition of human full-length RETMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 1.80nMAssay Description:Inhibition of RET V804M mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 2.10nMAssay Description:Inhibition of RET V804M mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 2.30nMAssay Description:Inhibition of RET V804L mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 2.30nMAssay Description:Inhibition of RET V804L mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 2.60nMAssay Description:Inhibition of RET V804L mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of RET M918T mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 3.10nMAssay Description:Inhibition of RET V804L mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 3.20nMAssay Description:Inhibition of wild type RET (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 3.60nMAssay Description:Inhibition of wild type RET (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 3.80nMAssay Description:Inhibition of wild type RET (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of RET V804L mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 4.70nMAssay Description:Inhibition of RET V804L mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 4.70nMAssay Description:Inhibition of RET M918T mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 4.80nMAssay Description:Inhibition of wild type RET (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 4.90nMAssay Description:Inhibition of RET M918T mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 5.10nMAssay Description:Inhibition of RET M918T mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetVascular endothelial growth factor receptor 3(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 5.10nMAssay Description:Inhibition of FLT4 (unknown origin) by FRET-based Z-Lyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 5.20nMAssay Description:Inhibition of RET (unknown origin)More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 5.5nMAssay Description:Inhibition of wild type RET (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 5.60nMAssay Description:Inhibition of RET V804L mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 5.70nMAssay Description:Inhibition of RET G810S mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 5.70nMAssay Description:Inhibition of wild type RET (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 5.90nMAssay Description:Inhibition of RET M918T mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 5.90nMAssay Description:Inhibition of wild type RET (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 5.90nMAssay Description:Inhibition of recombinant wild type RET (unknown origin) extracted from baculovirusMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 6.5nMAssay Description:Inhibition of RET M918T mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 6.70nMAssay Description:Inhibition of RET M918T mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 6.70nMAssay Description:Inhibition of wild type RET (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 7.10nMAssay Description:Inhibition of RET G810C mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 7.60nMAssay Description:Inhibition of wild type RET (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 8.30nMAssay Description:Inhibition of RET G810R mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 8.5nMAssay Description:Inhibition of RET V804L mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 9.10nMAssay Description:Inhibition of wild type RET (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 9.30nMAssay Description:Inhibition of RET M918T mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 9.80nMAssay Description:Inhibition of wild type RET (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Inhibition of RET M918T mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Inhibition of RET V804L mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Inhibition of wild type RET (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of RET V804L mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of RET V804L mutant (unknown origin) by FRET-based ZLyte kinase assayMore data for this Ligand-Target Pair
Ligand Info


















